Contineum Therapeutics Advances Promising Therapies in Neuroscience and Immunology Amid Market Volatility
Contineum Therapeutics is a clinical-stage biopharmaceutical company advancing breakthrough therapies in neuroscience and immunology, with a promising pipeline of novel treatments for conditions such as idiopathic pulmonary fibrosis and multiple scl…
2 minutes to read